Literature DB >> 3959902

Cancer cachexia and the rate of whole body lipolysis in man.

M Jeevanandam, G D Horowitz, S F Lowry, M F Brennan.   

Abstract

While malnutrition attending cancer cachexia may be associated with variable losses of body fat, lipid metabolism has been only minimally studied. To clarify potential aberrations of lipid metabolism in weight losing cancer patients, the whole body rate of lipolysis was determined in 9 cancer patients in the postabsorptive state and compared to that in 5 normal subjects. A primed-three stage infusion of glycerol was used to measure plasma glycerol clearance and turnover. A positive correlation between glycerol turnover and plasma concentration was demonstrated in both cancer patients (r = 0.72) and in normal subjects (r = 0.81). Glycerol turnover rate in cancer patients (2.05 +/- 0.14 mumol X kg-1 X min-1) was not different from that in normals (2.31 +/- 0.50); while glycerol clearance in cancer patients (1.72 +/- 0.13 L/min) was significantly lower (P less than 0.025) by 32% than that in normals. This study demonstrates that the whole body lipolytic rate in cancer patients is not different from healthy normals. As a consequence, the loss of body fat in patients with cancer cachexia may be due to a reduced rate of lipogenesis rather than augmented lipolysis as is observed in nonmalignant malnutrition, starvation, or injury.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3959902     DOI: 10.1016/0026-0495(86)90145-9

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

Review 1.  Metabolic alteration in patients with cancer: nutritional implications.

Authors:  Y Sakurai; S Klein
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

2.  Increased urinary excretion of cortisol and catecholami-NES in malnourished cancer patients.

Authors:  C Drott; G Svaninger; K Lundholm
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

3.  Whole-body lipolysis and triglyceride-fatty acid cycling in cachectic patients with esophageal cancer.

Authors:  S Klein; R R Wolfe
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

4.  Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice.

Authors:  Jose M Garcia; Thomas Scherer; Ji-an Chen; Bobby Guillory; Anriada Nassif; Victor Papusha; Joanna Smiechowska; Mark Asnicar; Christoph Buettner; Roy G Smith
Journal:  Endocrinology       Date:  2013-07-05       Impact factor: 4.736

Review 5.  Computational modeling of cancer cachexia.

Authors:  Kevin D Hall; Vickie E Baracos
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-05       Impact factor: 4.294

Review 6.  Perioperative care of the oncology patient.

Authors:  C J Kelly; J M Daly
Journal:  World J Surg       Date:  1993 Mar-Apr       Impact factor: 3.352

7.  Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients.

Authors:  P Groundwater; S A Beck; C Barton; C Adamson; I N Ferrier; M J Tisdale
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

8.  Lipogenesis in tumour and host tissues in mice bearing colonic adenocarcinomas.

Authors:  H D Mulligan; M J Tisdale
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

Review 9.  Evidence and mechanisms of fat depletion in cancer.

Authors:  Maryam Ebadi; Vera C Mazurak
Journal:  Nutrients       Date:  2014-11-19       Impact factor: 5.717

Review 10.  Potential Biomarkers of Fat Loss as a Feature of Cancer Cachexia.

Authors:  Maryam Ebadi; Vera C Mazurak
Journal:  Mediators Inflamm       Date:  2015-10-05       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.